Engineering biological systems at the molecular level has opened new frontiers in medicine, agriculture, and sustainable manufacturing. The design of synthetic pathways enables the production of bio-based chemicals, pharmaceuticals, and high-value biomaterials with enhanced efficiency. Advances in genetic circuit construction and CRISPR-based genome editing allow precise control over metabolic networks, leading to the creation of tailor-made biomolecules. In drug discovery, synthetic peptides and nucleic acid-based therapeutics provide innovative treatment strategies for complex diseases. The development of artificial enzymes and biomimetic catalysts expands possibilities in green chemistry and industrial bioprocessing. By merging principles of chemistry, biology, and engineering, synthetic biology & designer molecules continues to revolutionize biotechnology, offering solutions for personalized medicine, environmental sustainability, and next-generation biomaterials.
Title : Fighting antibiotic resistance: Eliminating implant infections in humans without antibiotics
Thomas J Webster, Brown University, United States
Title : Novel polymer-mediated therapeutic options for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Turning problems into opportunities via small molecule design
Brian Blagg, University of Notre Dame, United States
Title : Durable surface-confined metal-terpyridine architectures for electrochromic applications
Olena Zenkina, Ontario Tech University, Canada
Title : Advances in plasma-based waste treatment
Hossam A Gabbar, Ontario Tech University, Canada
Title : Application of the Michaelis-Menten formalism to hydrocracking-related reactions and analysis of the features of the reactors
Orchidea Maria Lecian, Sapienza University of Rome, Italy